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SObjective: Intrathoracic esophageal anastomotic leaks and perforations are very morbid and challenging prob-
lems. Esophageal stents are increasingly playing an integral role in the management of these patients. Our ob-
jective was to report our experience with esophageal stent placement for anastomotic leaks and perforations and
to provide a treatment algorithm.
Methods: We performed a review of patients with stent placement for esophagogastric anastomotic leaks or
esophageal perforation from March 2005 to August 2009. A prospective database was used to collect data. Suc-
cess was defined as endoscopic defect closure, negative esophagram, and resumption of oral intake. Failure was
defined as no change in leak size or clinical signs of ongoing infection. We collected and analyzed patient de-
mographics, diagnosis, clinical history, and poststent outcomes using descriptive statistics.
Results: Thirty-seven patients underwent esophageal stent placement for anastomotic leaks (n ¼ 22) and per-
forations (n ¼ 15). The median time from original procedure to diagnosis of leak or perforation was 6 days
(0–420 days). Nineteen patients (51%) had 21 associated procedures for source control. We placed 94 stents
(mean ¼ 2.7 stents/patient); 16 patients (43%) required more than 1 stenting procedure (mean ¼ 1.8 proce-
dures/patient). The median time to restoration of esophageal integrity was 33 days (7–120 days). There were
22 successes (59%); 2 failures were secondary to undrained abscess. Only 2 failures occurred in the last 15 pa-
tients (88% success). Strictures did not develop in any patients. Serious complications occurred in 3 patients
(stent erosion, leak enlargement, fatal gastroaortic fistula).
Conclusions: Esophageal stents can potentially play an integral role in the management of anastomotic leaks
and perforations. Success depends on appropriate procedures for source control and surgeon experience.
(J Thorac Cardiovasc Surg 2011;142:39-46)Supplemental material is available online.Earn CME credits at
http://cme.ctsnetjournals.org
Intrathoracic anastomotic leaks postesophagectomy and
esophageal perforations are a major source of morbidity
(10%–60%) and mortality (4%–50%); furthermore, 10%
to 50% of patients develop strictures requiring dilations.1-9
To date, no unified approach is available to treat these
complex problems. Some investigators suggest aggressive
operative intervention (eg, surgical exploration and repaire Division of Thoracic and Foregut Surgery, Department of Surgery, Univer-
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The Journal of Thoracic and Cor gastric conduit takedown with diversion) for patients
with postesophagectomy intrathoracic anastomotic leak,
whereas others recommend nonoperative management
with total parenteral nutrition, perianastomotic drainage,
and broad-spectrum antibiotics.5,10-15 Guidelines for either
approach are not well defined, and most thoracic surgeons
incorporate clinical judgment in the therapeutic decision-
making process. The decision most often is based on the lo-
cation and size of the leak or perforation and the patient’s
overall clinical condition.
In recent years, several reports have described the use of
endoscopically placed esophageal stents for the treatment
of leaks and perforations.16-e37 These case series include
heterogeneous patient populations, a variety of stent
types (mostly metallic), mixed management concepts,
and overall success rates of 60% to 90%.e38 However,
the very diverse nature of published reports, including
ill-defined outcome measures, creates a challenge for sur-
geons willing to entertain this therapeutic option for pa-
tients with esophageal intrathoracic anastomotic leaks or
perforations.
The aim of the present study is to demonstrate the utility
of esophageal stents in patients with esophageal intratho-
racic anastomotic leaks or perforations. Further, we seek
to propose a stent-based treatment algorithm for these
very challenging patients.ardiovascular Surgery c Volume 142, Number 1 39
Abbreviation and Acronym
CT ¼ computed tomography
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SMATERIALS AND METHODS
Study Design and Patient Selection
We performed an institutional review board-approved retrospective re-
view of our prospectively held esophageal stent database fromMarch 2005
to August 2009. All patients were treated at the University of Minnesota.
Esophageal anastomotic leak or perforation was diagnosed by one or sev-
eral diagnostic tests: esophagram, endoscopy with fluoroscopy and intrao-
perative contrast injection, and computed tomography (CT) imaging of the
neck, chest, and abdomen. We excluded patients with anastomotic leaks
secondary to gastric tip necrosis; gastric conduit necrosis; leaks or perfora-
tions within 2 cm of the cricopharyngeus muscle; perforated esophageal
cancer; and tracheoesophageal fistula secondary to a leak or perforation.
Patients who were managed conservatively with low output leaks were
also excluded from this study.
Esophageal Stent Placement
All stents were placed by thoracic surgeons with the patient in the oper-
ating room, under general anesthesia, and in the supine position with the
head of the bead elevated 30 to 45 degrees. Endoscopy and fluoroscopy
were used. When there was doubt about the location and size of the leak,
these were evaluated with intraoperative contrast injection (iodixanol
[Visipaque; GE Healthcare Inc, Princeton, NJ]), which is safer in case of
aspiration. We then passed a stiff-shaft guidewire (0.035 mm, 260 cm)
through the endoscope into the distal stomach or first portion of the duode-
num, removed the endoscope, and deployed the esophageal stent(s) over
the wire using fluoroscopic guidance. We used fully covered nitinol stents
(ALIMAXX-E; Alveolus, Charlotte, NC) or silicone stents (Polyflex; Bos-
ton Scientific, Natick, Mass). The decision to place 1 or 2 stents depended
on the cause and properties of the leak or perforation as detailed below.
Esophagogastric Anastomotic Leak
In patientswith an esophagogastric anastomotic leak, the esophagus is of
normal caliber, and the gastric conduit has a significantly larger diameter
than the esophagus. A conventional stent with only a proximal flare will
fit securely in the esophagus but will not completely seal the leak: The
size discrepancy between the stent and the stomach allows gastric contents
to reflux around the distal end of stent and continue leaking through the
anastomotic defect. Tominimize this problem, we used a double-stent, dou-
ble-flare (dumbbell) technique: The largest available Polyflex silicone stent
(diameter: 21-mm shaft, 25-mm flare) was placed upside down across the
anastomosis so that the flare was in the stomach (only a Polyflex stent can
be easily loadedupside down); next, we placed a second stent (any fully cov-
ered type, 21–23-mm shaft) upside up into the first stent, creating a double-
flare (dumbbell) stent arrangement (Figure 1). We developed the dumbbell
technique so that the distal flare would reduce the possibility of peri-stent
reflux in the conduit (Figure 2). We believe the use of the double flare strat-
egy minimizes migration and provides better leak occlusion. We recognize
this is not the only potential strategy, particularly in light of the more recent
availability of double-flared, fully-covered stents in the United States; how-
ever, during the time period of this study, double-flared stents were not ac-
cessible for clinical practice.
Esophageal Perforation
Patients with an esophageal perforation often have an associated stric-
ture; thus, we chose a stent diameter that was appropriate for the particular
situation. Although a single stent was mainly used in this setting, selected40 The Journal of Thoracic and Cardiovascular Surgepatients required the 2-stent, dumbbell technique described above to max-
imize the seal for control of the perforation.
Additional Management Considerations
Aswe gained experience, we increasingly used long stents (12–15 cm) to
minimizemigration.After stent placement,we again injected contrast tover-
ify leak occlusion. Nasogastric tubes were not routinely used. Additionally,
weperformedany indicateddrainage procedures for source control (neck ex-
ploration and drainage, mediastinal irrigation, video-assisted thoracoscopy,
thoracotomy) depending on the clinical status and imaging studies.
Stent Surveillance and Patient Follow-up
Patients continued to receive intravenous broad-spectrum antibiotics
and antifungal agents postoperatively. We obtained routine postoperative
chest x-rays in the postanesthesia care unit to document stent position
and routinely obtained daily chest x-rays for at least 72 hours to assess po-
sition and screen for stent migration. In addition to performing an esopha-
gram intraoperatively, we repeat the esophagram in patients who are able to
swallow at 24 to 48 hours after stent placement. If we find absence of on-
going leak on this initial study, we initiate oral intakewith clear liquids. Al-
though our goal was to provide oral intake as soon as able, we also provided
supplemental nutrition to patients as indicated. All patients undergoing
esophagectomy had jejunostomy tubes. The patients with spontaneous per-
forations all underwent gastrostomy or jejunostomy tube placement if un-
able to take oral intake within 5 days. We generally obtained an
esophagram within 2 to 4 weeks of stent placement once the patient had
passed a swallow examination by our speech pathologists (Gastrografin
[Bracco Diagnostics Inc, Princeton, NJ], barium, or both). All patients re-
quired routine aspiration precautions, and any stent across the gastroesoph-
ageal junction mandated high-dose proton pump inhibitor therapy. We
routinely planned stent removal after 3 to 4 weeks to allow for healing of
the defect and to monitor for gastric conduit erosion related to the distal
end of the stent. We then reassessed defects endoscopically and fluoroscop-
ically with contrast injection and, if needed, replaced stents. This was in-
dividualized by patient according to cause, size, and location of the
defect; nutritional status; and resolution of infection.
Outcomes
Success was defined as endoscopic defect closure, negative esopha-
gram, and resumption of oral intake without signs of clinical infection.
Failure was defined as no change in leak size or ongoing infection. Patients
deemed as failures underwent stent removal and operative intervention.
Once discharged from the hospital, outpatients were routinely assessed
by esophagram and CT scan, if indicated.
Data Analysis
All clinical parameters were documented prospectively using our data-
base. Continuous data for our investigation were reported as mean (or me-
dian)  standard deviation.RESULTS
During the 4-year evaluation period, 37 patients were
identified to have esophageal anastomotic leaks or esopha-
geal perforations. The mean age of patients was 60 years
(range, 19–83 years); 26 were male and 11 were female.
There were 22 (59.5%) anastomotic leaks and 15
(40.5%) perforations. Table 1 delineates the cause of esoph-
ageal perforations. The anastomotic leaks occurred in 20
patients who had undergone esophagectomy with intratho-
racic anastomosis and 1 patient with a cervical anastomosis.ry c July 2011
FIGURE 1. Intraoperative fluoroscopic image. This represents the
‘‘dumbbell technique’’ of applying Polyflex stents in overlapping fashion.
The leak was located between the 2 needle markers.
TABLE 1. Original procedures performed in patients presenting with
esophageal perforation
Procedure No. %
Collis gastroplasty 1 6.7
Laparoscopic gastric band 1 6.7
Thoracoscopic leiomyoma resection 1 6.7
Laparoscopic Heller myotomy 1 6.7
Foreign body extraction 3 20
Stricture dilation 4 26.7
Percutaneous gastrostomy tube 1 6.7
Mediastinoscopy 1 6.7
Spontaneous perforation 2 13.3
Total 15 100
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anastomotic leaks, 10 (47.6%) had undergone preoperative
radiation or chemotherapy. The diagnosis of clinically sus-
pected leaks was established via an esophagram. One addi-FIGURE 2. Retrograde reflux around stent resulting in persistent leak. In-
traoperative fluoroscopic contrast study from a patient with a leak post-
esophagectomy. A single Polyflex esophageal stent was placed across the
leak, and retrograde reflux of contrast was seen at the distal portion of the
stent. Therewas a persistent leak in this patient, as seen in the contrast image.
Deployment of our stenting technique as used in Figure 1 solved this issue.
The Journal of Thoracic and Ctional patient had an anastomotic leak after total
gastrectomy. All patients undergoing stent treatment were
not able to be managed conservatively because of lack of
source control.
The median time from the original procedure to the diag-
nosis of leak or perforation was 6 days (range, 0–420 days)
(leak median, 7.5 days; range, 1–420; perforation median, 2
days; range, 0–15). The outlying patient diagnosed 420
days postoperatively had undergone esophagectomy fol-
lowed 6months later by attempted stricture dilation compli-
cated by perforation at an out-of-state institution. Eighteen
patients (48.6%) were stented the same day their leak or
perforation was diagnosed; another 3 patients (8.1%)
were stented within the first 24 hours. Importantly, 19 pa-
tients (51.4%) had an additional 21 procedures performed
to achieve source control (Table 2). These 19 patients re-
quiring additional drainage procedures included 10
(60.0%) with leaks and 9 (45.4%) with perforations. Chest
drainage and decortication were the most common associ-
ated procedures (n ¼ 14, 66.7%).
We placed a total of 94 stents (mean ¼ 2.7 stents/patient;
Polyflex-69, Alimaxx-24, and 1 partially covered nitinol
stent [Ultraflex; Boston Scientific]). The breakdown of
the mean number of stents required by subgroup included
3.0/patient for leaks and 2.0/patient for perforations. Six-
teen patients (43.2%) required more than 1 stenting proce-
dure (mean¼ 1.8 stenting procedures/patient; 14 days to 21
days after initial stent placement); half of re-stenting proce-
dures were performed for scheduled, routine reevaluation
of the leak or perforation, and half were undertaken for
stent-related complications (Table 3). In the leak subgroup,
16 of 22 patients had stents placed using the 2-stent ap-
proach. In the perforation subgroup, patients typically
had 1 stent placed to control the leak, and only 2 of 15 pa-
tients required the double-stenting technique. Re-stenting
procedures were required in 10 patients (45.4%) with leaks
and in 6 patients (40.0%) with perforations. Importantly,
no patients required dilation for esophageal stricture after
resolution and stent removal, with a mean follow-up time
of 41.6 months (range, 18.7–67.0 months). Stent migrationardiovascular Surgery c Volume 142, Number 1 41
TABLE 2. Source control procedures performed
Procedure No.
Thoracotomy with decortication 6
VATS with decortication 8
Percutaneous drain placement 1
Neck exploration and drainage 4
Laparoscopic exploration 2
Total 21
VATS, Video-assisted thoracoscopic surgery.
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ring in 16.2% of patients (4 [18.2%] leaks, 2 [13.3%] per-
forations). Serious complications occurred in 3 patients
(stent erosion, leak enlargement, and death from gastro-
aortic fistula). All of these complications occurred in pa-
tients postesophagectomy. None of these patients had been
treated with preoperative radiation or chemotherapy. Two
of the three patients had stents placed via dumbbell tech-
nique. Their initial management and hospital courses
were not atypical from those of the rest of the patients.
The development of the gastroaortic fistula was a rare and
lethal complication of esophageal stent placement, and
our detailed report of this devastating clinical scenario
serves as a warning of caution.e39 In this series, the overall
mortality directly related to esophageal leak was 13.5% (5
patients). The deaths occurred in the patient with gastro-
aortic fistula; in 1 patient with stenting success and unre-
lated multisystem organ failure, ultimately placed on
comfort care by family members; and in 3 patients with
stenting failures, placed in hospice in the face of uncon-
trolled sepsis. Four of these deaths occurred in patients
with anastomotic leaks (18.1% mortality in this subgroup),
and 1 death was in a patient with spontaneous perforation
(6.7% mortality).
Twenty-two patients (59.5%) were considered a stent
success by having complete resolution of their leak or per-
foration within a median time of 33 days (range, 7–120
days). This included 13 patients (59.1%) with esophago-
gastric anastomotic leak, whose median time to resolution
was 40.5 days (range, 22–120 days); for patients with per-
foration, the median time for resolution was 27 days (range,
5–41 days), with success in 9 (60.0%). The largest anasto-
motic leak treated successfully encompassed approximately
50% of the original anastomotic circumference (Figure 3).
For these 22 successes, the median time to oral intake was 3
days (range, 0–69 days). For leaks successfully treated withTABLE 3. Stent-related complications
Complication No. % of total cases (n ¼ 37)
Stent migration 6 16.2
Enlargement of original leak 1 2.7
Stent erosion 1 2.7
Gastroaortic fistula 1 2.7
Total 9 24.3
42 The Journal of Thoracic and Cardiovascular Surgestents, the median time to oral intake was 6 days (range,
0–69 days). For perforations successfully treated, the median
time to oral intake was 3 days (range, 1–43 days). Reasons
for stent failure are listed in Table 4; the major reason for
unsuccessful stent placement was nonseal of esophageal
leak or perforation requiring definitive surgical interven-
tion. Notably, we achieved an 88.2% success rate for clo-
sure of leak or perforation in the 15 most recently treated
patients (17 total). As our experience grew, 9 patients
(24.3%) with an immediately diagnosed iatrogenic perfora-
tion underwent stent placement, esophagogram the next
day, and started oral intake on postoperative day 1. They
were discharged at a median of 5 days (range, 2–33 days)
on oral antibiotics and eating a mechanical soft diet.
DISCUSSION
Postesophagectomy anastomotic leaks and esophageal
perforations are serious morbid events. Regardless of the
cause and clinical condition of the patient, the principles
of management are standardized: resuscitation, broad-
spectrum antimicrobial therapy, drainage of contaminated
areas, and source control (control or closure of the defect).
Despite adherence to these principles and advances in inten-
sive unit care, the morbidity (10%–60%) and mortality
(4%–50%) associated with esophageal leaks and perfora-
tions are still very high; furthermore, strictures requiring di-
lations develop in 10% to 50% of patients.1-9 Our report
presents the 2 patient populations, with anastomotic leaks
and perforations, as one group because the principles of
management outlined above are the same for both.
Additionally, either event alone is uncommon; hence,
other investigators have also mixed these 2 patient
populations in the same manner to accumulate a series of
relevant size.16,24
Our findings indicate that esophageal stent placement for
leaks and perforations facilitates source control, prevents
stricture formation, and, in select cases, allows for early
oral intake. However, success depends on a uniform ap-
proach that focuses on appropriate patient selection, proper
stent placement technique, thorough drainage procedures,
and meticulous postoperative care.
Patient Selection
We place a stent in any patient with an esophageal anas-
tomotic leak or perforation following the algorithm outlined
in Figure 4. Of note, we have not had any problems per-
forming endoscopy and stent placement for anastomotic
leaks as early as the third postoperative day in patients
postesophagectomy. Exceptions to stenting as primary ther-
apy for this problem include patients with gastric tip or
conduit necrosis, leaks or perforations within 2 cm of the
cricopharyngeus muscle, perforated cancer, and tracheoeso-
phageal fistula secondary to a leak or a perforation. Patients
with severe conduit ischemia generally require revision orry c July 2011
FIGURE 3. Endoscopic progression of leak closure. A, Dramatic postesophagectomy anastomotic leak draining directly into the left pleural space; a blue
pleural pig-tail catheter is clearly visible. B, Near-complete healing 19 days after stent placement and left decortication, with only a pinpoint leak remaining
(arrow). C, Stents were replaced at day 19 and definitively removed on day 32; an esophagram confirmed complete resolution.
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copharyngeus is extremely uncomfortable. Patients with
a perforated esophageal cancer should preferably undergo
resection because a perforated tumor is unlikely to seal
with a stent; however, this decision should be individual-
ized, and this may be adequate therapy in the palliative set-
ting. Patients with a tracheoesophageal fistula secondary to
a leak or perforation are extremely complex and should onlyTABLE 4. Stent-related outcomes
Outcome n %
Success 22 59.5
Reason for failure
Nonseal of leak 9 24.3
Stent erosion 2 5.4
Kinked stent 1 2.7
Stent malposition 1 2.7
Early withdrawal of care (multisystem organ failure) 1 2.7
Gastroaortic fistula 1 2.7
Total 37 100
The Journal of Thoracic and Cbe considered for esophageal stent placement as a bridge to
a definitive repair. Although we had 1 patient with total gas-
trectomy in our series, in general, we believe an esophago-
jejunostomy leak should have an individualized approach
that favors not undergoing stent placement, because the
small bowel wall is susceptible to stent-induced erosion
and perforation.
One must be prepared to perform more extensive inter-
ventions, such as mediastinal drainage or decortication, if
the leak or perforation has been present for more than 24
hours and there is clinical or radiologic evidence of deep
space infection. After considering the above exclusions,
2 key principles dictate whether a patient is an appropriate
candidate for esophageal stent placement: luminal diame-
ter and vertical orientation. If the diameter of the esopha-
gus or conduit is too large, no stent will be large enough to
cause apposition and sealing; if a gastric conduit is angled,
then the distal portion of the stent will initially be occluded
by the gastric wall and will eventually perforate the
conduit.ardiovascular Surgery c Volume 142, Number 1 43
FIGURE 4. Treatment algorithm for esophageal stent placement in patients with esophageal leaks or perforations. CT, Computed tomography; EGD,
esophagogastroduodenoscopy; POD, postoperative day.
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Successful stent placement for an esophageal anasto-
motic leak or perforation depends on several technical con-
siderations:
(1) Stent choice: We use only fully covered nitinol or sili-
cone stents and preferably deploy them with the dumb-
bell technique. Our decision to use this technique prior
to the availability of fully covered, double-flared stents
was based entirely on our empirical observations of im-
proved leak sealing in patients postesophagectomy. In
our experience, the procedure is not more challenging
than single-stent placement. Recently, however, a fully
covered, double-flared nitinol stent has been released in
the United States (Wallflex; Boston Scientific). This has
the potential to obviate the need for dumbbell stent
placement and is our current esophageal stent of choice
for leaks and perforations. We believe that using long
stents with a large diameter improves sealing and re-
duces migration, and this is the principle to which one
must adhere. Our migration rate was only 16.2%,
which compares favorably to reported migration rates
as high as 63% in some series.e40
(2) Intraoperative seal: We leave a stent in place only if we
can confirm a satisfactory intraoperative seal; other-
wise, a stent needs to be repositioned or removed alto-
gether. An improperly placed stent provides no source
control and only adds to the risk of complications (ie,
erosion, perpetuation of the leak, aspiration, and ob-44 The Journal of Thoracic and Cardiovascular Surgestruction). Our intraoperative technical success was
95%, consistent with that of other recent reports.16,e41
Additional Procedures
If indicated for optimum source control, additional drain-
age procedures following basic surgical principles are imper-
ative. In our experience, 51% of patients required an
additional procedure at the time of esophageal stent place-
ment. Of note, 52.3% of patients (11/21) who required
deep space drainage underwent a minimally invasive proce-
dure (video-assisted thoracoscopy, percutaneous drainage,
or laparoscopy). However, we do not hesitate to convert to
an open procedure if needed. The patient’s outcome depends
on the quality of the initial stent placement technique in com-
bination with an appropriate drainage procedure if indicated.
Postoperative Management
Certain aspects of postoperative management deserve
emphasis:
(1) Radiologic follow-up: Daily chest radiographs are ob-
tainedat least in thefirst 72hours towatch for stentmigra-
tion. Prior to oral intake, patients undergo an esophagram
when clinically appropriate. The timingof this evaluation
varies significantly. Although an initially critically ill pa-
tient may take several weeks to recover sufficiently
enough to undergo a swallow evaluation by a speech pa-
thologist prior to attemptinganesophagram, patientswho
present within the first 24 hours of perforation withry c July 2011
FIGURE 5. Gastric conduit mucosal erosion. After removal of a stent that
had been in place for 3 weeks, mucosal erosion was seen. The arrows point
to the area where the distal edge of the stent had been in contact causing
mucosal irritation. If stent replacement is required, careful attention to
this area is made and the replacement stent is placed proximally or distally
to the injured region.
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after stent placement. Once an esophagram has demon-
strated sealing, patients may then start oral intake (clear
liquids). In our studypopulation, 9 patients startedoral in-
take shortly after stent placement and were discharged
within 4 days on oral antibiotics.
On occasion, we demonstrate proper seal intraopera-
tively, but some distal peri-stent refluxate leaks when the
patient undergoes a formal esophagram. Under these cir-
cumstances, we leave the stents in place if we see that the
leak is smaller than on initial presentation and the patient
is improving clinically; we will then repeat the esophagram
after 1 or 2 more weeks of continued clinical improvement.
Any indication of clinical deterioration mandates radiologic
investigation, preferably CT scan, or even immediate rein-
tervention. We liberally return deteriorating patients to the
operating room for endoscopic, fluoroscopic, and, if neces-
sary, operative reassessment.
(2) Stent exchange: We routinely remove the initial stent(s)
within 3 to 4 weeks of placement and reevaluate the
leak or perforation with endoscopy and fluoroscopy.
We adopted this approach early in our experience, be-
cause we became concerned about gastric-conduit mu-
cosal erosion over time at the distal end of the stent. In
contrast with other recent reports, all stents in our series
were easily removed without complications.e42 If we
demonstrate sealing at the time of stent reevaluation,The Journal of Thoracic and Cbut we believe the patient is at risk for stricture forma-
tion (eg, a patient who had an iatrogenic perforation for
a preexisting benign stricture), we will replace a stent
and leave it in place for another 4 weeks. Our approach
resulted in the use of 2.7 stents per patient. If we replace
a stent in a patient with an esophagogastric anastomotic
leak, we ensure that the distal end of the stent is at a dif-
ferent level than the initial stent(s) so that mucosal ero-
sion occurs in a different place and the previous area of
damage is allowed to heal (Figure 5).
(3) Antimicrobial therapy: All patients receive broad-
spectrum antibiotics and antifungals, and we tailor
therapy according to clinical course and culture results.
Antibiotics are discontinued on determination of suc-
cess (endoscopic defect closure, negative esophagram,
and resumption of oral intake without signs of clinical
infection).
A number of investigators have reported the successful ap-
plication of endoluminal stents for esophageal leaks and per-
forations onheterogeneouspatient populations, using a range
of stent types and variable management strategies.16-e37
Results have been promising; however, no unified approach
has been proposed. In a recently published series of 32
patients with leaks or perforations, Tuebergen and
colleagues16 reported an initial intraoperative seal rate of
78%, a stent complication rate of 28%, a 15% mortality
rate, an overall success rate of 59%, and a stricture rate of
9%. Freeman and colleagues22,23,e41 have published some
of the most comprehensive reports on this subject. In their
most recent case series, they effectively placed stents in 19
patients with spontaneous perforation of the esophagus.
Leak occlusion occurred in 17 patients (89%), and 15
patients (79%) started oral intake within 72 hours of stent
placement. Stents were removed at a mean of 20 days after
placement with an overall success rate of 79%.e40
In our report,we achieved successful intraoperative leakor
perforation occlusion in 95% of patients. We observed
a stent-related complication rate of 24%, a 14% overallmor-
tality rate, an overall success rate of 60%, and no strictures.
The rate of complete resolution improved aswe gained expe-
rience, reaching 88% success in our last 15 patients (2 fail-
ures). We believe that the high success rate in the latter half
of our series is a direct result of using our uniform manage-
ment algorithm (Figure 4), which was established through
our experience and progression on a learning curve with
stent-based therapy for esophageal leaks and perforations.
Patients with esophagogastric anastomotic leaks tended to
take longer to achieve resolution than patients with an esoph-
ageal perforation (40.5 vs 21 days); this is most likely ex-
plained by patient-related factors (eg, malnutrition,
systemic inflammation, immunosuppression, and neoadju-
vant therapy), a larger lumen-to-stent size discrepancy, and
more tissue ischemia in patients post-esophagectomy.ardiovascular Surgery c Volume 142, Number 1 45
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scopic surveillance is a critical component to ensure that
these patients aremaking satisfactory progress. Interestingly,
noneof our successfully treated patients developed a stricture
that required dilation, probably because the stent acts as
a mold during healing and scarring. The significance of the
absence of strictures in this population is highlighted by com-
parison with our 10% incidence of strictures requiring dila-
tion after esophagectomy in patients without an anastomotic
leak. Our results with esophageal stent placement for
anastomotic leaks and perforations, as well as the results of
others,16,22,23,e26,e30,e38,e40 compare favorably with the overall
results of the traditional management of these patients.e38
Study Limitations
We acknowledge that our study is not without limitations.
We have presented a retrospective review of a small and het-
erogeneous group of patients with an uncommon clinical
problem. This type of case series also runs the risk of selec-
tion bias, although we tried to mitigate this by providing
clear selection criteria. A comparison group of patients
without stent therapy would be beneficial to emphasize
our findings; unfortunately, we cannot provide such a group,
because stent therapy has become our standard of care for
this patient population. However, the series reported con-
sists of a number of individuals in our earlier stent experi-
ence who failed stentless management strategies prior to
successful treatment with stenting, thereby essentially serv-
ing as their own matched controls. One such example is
a man whose postesophagectomy leak was identified on
postoperative day 3, with unsuccessful attempts at stentless
management for 8 weeks. The problem was resolved within
3 weeks of stent therapy. Further, not only do the stents
seem to expedite resolution in such cases, but also these pa-
tients are able to take oral nutrition at an earlier time point
than those undergoing stentless therapies, an advantage that
should not be overlooked. One of the main goals of stent
placement is to resume oral intake as soon as possible,
a very important quality-of-life consideration. Conse-
quently, a patient with a small or contained leak without ev-
idence of uncontrolled deep space infection, who cannot eat
for medical reasons (eg, respiratory failure, aspiration),
would not benefit from stent placement.
CONCLUSIONS
Despite these limitations, our series is one of the largest
reported to date, and we provide a treatment algorithm
that includes proper patient selection, meticulous stent
placement technique, aggressive drainage of deep space in-
fection, broad-spectrum antimicrobial therapy, and intense
postoperative care. Our algorithm and experience strongly
support the serious consideration of a therapeutic paradigm46 The Journal of Thoracic and Cardiovascular Surgeshift in this challenging patient population, and future stud-
ies are clearly warranted.
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